These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7086265)

  • 21. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 23. Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.
    Ihlen H; Ditlefsen L
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):720-6. PubMed ID: 812650
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
    Lekieffre J; Vaur L; Kacet S; Lacroix D
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pure red cell aplasia associated with administration of sustained-release procainamide.
    Giannone L; Kugler JW; Krantz SB
    Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release procainamide in patients with myocardial infarction.
    Birkhead J; Evans T; Mumford P; Martinez E; Jewitt D
    Br Heart J; 1976 Jan; 38(1):77-80. PubMed ID: 1252299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Evaluation of anti-arrhythmic efficacy of perhexiline maleate in ambulatory patients by Holter monitoring.
    Drake FT; Haring O; Singer DH; Dirnberger G
    Postgrad Med J; 1973 Apr; 49():Suppl 3:52-63. PubMed ID: 4587033
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quinidine interactions with propranolol, phenytoin, verapamil and procainamide].
    Halawa B
    Pol Tyg Lek; 1984 Jun; 39(24):823-6. PubMed ID: 6494041
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experience with lidocaine in the treatment of cardiac arrhythmias].
    Pellegrino L; Casari A; Salerno J
    Clin Ter; 1971 Nov; 59(3):213-28. PubMed ID: 5160468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interaction of phenytoin with propranolol, procainamide and digoxin].
    Halawa B
    Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of the acetylation phenotype and the therapeutic effect of procainamide.
    Schröder P; Klitgaard NA; Simonsen E
    Eur J Clin Pharmacol; 1979 Feb; 15(1):63-8. PubMed ID: 84761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
    Kusowska J
    Acta Pol Pharm; 1988; 45(4):346-50. PubMed ID: 3245471
    [No Abstract]   [Full Text] [Related]  

  • 33. Procaineamide blood levels after administration of a sustained-release preparation.
    Cunningham E; Sloman G
    Med J Aust; 1977 Mar; 1(11):370-2. PubMed ID: 870815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-polymer combinations. Part 1: The preparation of sustained release drugs by combination with ion exchanging resins.
    Gyselinck P; van Severen R; Braeckman P; Schacht E
    Pharmazie; 1981 Nov; 36(11):769-72. PubMed ID: 7323125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of the effectiveness and stability of action of sustained-release disopyramide phosphate by the Holter method].
    de Lombera Romero F; Martínez-Osorio Corzan L; Seoane J; Franco JR
    Rev Esp Cardiol; 1985; 38(6):446-50. PubMed ID: 2419948
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the efficacy of propafenone in rhythm disorders in childhood using Holter monitoring].
    Ranieri L; D'Alonzo S; Calvani V; Antoncecchi E; Antoncecchi E
    Minerva Cardioangiol; 1987 Mar; 35(3):87-90. PubMed ID: 3587666
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.
    Dahl SG; Fremstad D; Jacobsen S; Kvaleid I; Landmark KH; Lunde PK; Marthinsen AA; Nådland KJ; Waaler T
    Pharm Acta Helv; 1976; 51(7-8):204-8. PubMed ID: 967912
    [No Abstract]   [Full Text] [Related]  

  • 38. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Dose intervals for procainamide.
    Reidenberg MM
    Lancet; 1975 Jun; 1(7922):1429-30. PubMed ID: 49596
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.